CoChat

Antithrombotic Treatment for Recurrent Miscarriage: Bayesian Network Meta-Analysis and Systematic Review

Open access

The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.

Abstract

Combined use of heparin and aspirin is frequently prescribed for treatment of recurrent miscarriage (RM) in patients with antiphospholipid syndrome (APS), or in those without apparent cause of RM other than thrombophilia; however, this strategy is largely based on expert opinion and has not been well studied. The option for the use of different antithrombotic therapies to improve live birth remains unclear. In this network meta-analysis, we incorporated direct and indirect evidence to evaluate effects of different antithrombotic treatments on prevention of pregnancy losses.We searched PubMed and Embase for randomized clinical trials comparing effects of at least 2 antithrombotic treatments on live birth in RM patients published from 1965 through the early of May 2015. Potential risk bias of eligible trials was evaluated according to the Cochrane Collaboration guidelines. Bayesian network meta-analysis was used to estimate relative effects on live birth.A total of 19 trials involving 2391 RM patients with or without thrombophilia and 543 with APS were included. No beneficial effect of antithrombotic treatment was observed either in RM patients with or without thrombophilia or in patients with APS; however, for patients with or without thrombophilia, low molecular weight heparin therapy had the greatest probability (61.48%) of being the best option in terms of live birth; for patients with APS, unfractionated heparin plus aspirin was the superior treatment for RM with the highest possibility (75.15%) of being top 2 places for reducing pregnancy losses. Aspirin was inferior in both groups.Our results do not support the use of combined low molecular weight heparin and aspirin for RM treatment, and suggested aspirin may have negative effects for lowering the risk of pregnancy loss.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/md.0000000000001732

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIGURE 1 Flow diagram of the database search and trial selection process.
FIGURE 1 Flow diagram of the database search and trial selection process.CC BY-NC-ND · PubMed Central
FIGURE 2 Network among eligible treatments in patients with or without thrombophilia and patients with APS. The node size indicates the sample size in the treatment group that the node stands for; the thickness of the link represents the sample size of the direct comparisons. APS = antiphospholipid syndrome, LMWH = low molecular weight heparin, UFH = unfractionated heparin.
FIGURE 2 Network among eligible treatments in patients with or without thrombophilia and patients with APS. The node size indicates the sample size in the treatment group that the node stands for; the thickness of the link represents the sample size of the direct comparisons. APS = antiphospholipid syndrome, LMWH = low molecular weight heparin, UFH = unfractionated heparin.CC BY-NC-ND · PubMed Central
FIGURE 3 Forest plot for OR of live birth based on Bayesian network and traditional pair-wise meta-analyses in patients with or without thrombophilia. The black squares represent the pooled effect estimates, which mean the OR of live birth between the corresponding pair of drugs, whereas the horizontal lines depict the 95% credible intervals in Bayesian network meta-analysis and 95% confidence intervals in traditional pair-wise meta-analysis. LMWH = low molecular weight heparin, OR = odds ratio, UFH = unfractionated heparin.
FIGURE 3 Forest plot for OR of live birth based on Bayesian network and traditional pair-wise meta-analyses in patients with or without thrombophilia. The black squares represent the pooled effect estimates, which mean the OR of live birth between the corresponding pair of drugs, whereas the horizontal lines depict the 95% credible intervals in Bayesian network meta-analysis and 95% confidence intervals in traditional pair-wise meta-analysis. LMWH = low molecular weight heparin, OR = odds ratio, UFH = unfractionated heparin.CC BY-NC-ND · PubMed Central
FIGURE 4 Rank and cumulative probabilities of different antithrombotic treatments in patients with or without thrombophilia based on the protective effects on live birth. The horizontal axis represents the positions that the corresponding drug may rank at based on the protective effects on the outcome of live birth, whereas the vertical axis means the probabilities or the cumulative probabilities of the drug being ranked at the corresponding positions on the horizontal axis. For example, as the figure shows, the probabilities of aspirin being at first, second, third, and the last place for the protective effects on live birth are 0.5%, 2.4%, 15.07%, 82.03%, respectively, and the cumulative probabilities are 0.5%, 2.9%, 17.97%, 100%, respectively. LMWH = low molecular weight heparin.
FIGURE 4 Rank and cumulative probabilities of different antithrombotic treatments in patients with or without thrombophilia based on the protective effects on live birth. The horizontal axis represents the positions that the corresponding drug may rank at based on the protective effects on the outcome of live birth, whereas the vertical axis means the probabilities or the cumulative probabilities of the drug being ranked at the corresponding positions on the horizontal axis. For example, as the figure shows, the probabilities of aspirin being at first, second, third, and the last place for the protective effects on live birth are 0.5%, 2.4%, 15.07%, 82.03%, respectively, and the cumulative probabilities are 0.5%, 2.9%, 17.97%, 100%, respectively. LMWH = low molecular weight heparin.CC BY-NC-ND · PubMed Central
FIGURE 5 Forest plot for OR of live birth based on Bayesian network and traditional pair-wise meta-analyses in patients with APS. The black squares represent the pooled effect estimates, which mean the OR of live birth between the corresponding pair of drugs, whereas the horizontal lines depict the 95% credible intervals in Bayesian network meta-analysis and 95% confidence intervals in traditional pair-wise meta-analysis. APS = antiphospholipid syndrome, LMWH = low molecular weight heparin, OR = odds ratio, UFH = unfractionated heparin.
FIGURE 5 Forest plot for OR of live birth based on Bayesian network and traditional pair-wise meta-analyses in patients with APS. The black squares represent the pooled effect estimates, which mean the OR of live birth between the corresponding pair of drugs, whereas the horizontal lines depict the 95% credible intervals in Bayesian network meta-analysis and 95% confidence intervals in traditional pair-wise meta-analysis. APS = antiphospholipid syndrome, LMWH = low molecular weight heparin, OR = odds ratio, UFH = unfractionated heparin.CC BY-NC-ND · PubMed Central
FIGURE 6 Rank and cumulative probabilities of different antithrombotic treatments in patients with antiphospholipid syndrome based on the protective effects on live birth. The horizontal axis represents the positions that the corresponding drug may rank at based on the protective effects on the outcome of live birth, whereas the vertical axis means the probabilities or the cumulative probabilities of the drug being ranked at the corresponding positions on the horizontal axis. LMWH = low molecular weight heparin, UFH = unfractionated heparin.
FIGURE 6 Rank and cumulative probabilities of different antithrombotic treatments in patients with antiphospholipid syndrome based on the protective effects on live birth. The horizontal axis represents the positions that the corresponding drug may rank at based on the protective effects on the outcome of live birth, whereas the vertical axis means the probabilities or the cumulative probabilities of the drug being ranked at the corresponding positions on the horizontal axis. LMWH = low molecular weight heparin, UFH = unfractionated heparin.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 52 references

Cited by

See all 32

Metadata

Authors
Zhang, T., Ye, X., Zhu, T., XIAO, X., Liu, Y., Wei, X., Liu, Y., Wu, C., Guan, R., Li, X., Guo, X., Hu, H., & He, J.
Affiliations
Second Military Medical University (CN)
Corresponding author
He, Jia
Venue
Medicine
Published
2015-11
Volume
94
Issue
45
Pages
e1732
ISSN
0025-7974 (ISSN-L)
OpenAlex
W2315047914
Cited by
28
References
52
Citations by year
2025: 2 · 2024: 2 · 2023: 5 · 2022: 2 · 2021: 2 · 2020: 3 · 2019: 4 · 2018: 3 · 2017: 4 · 2016: 1
FWCI
0.25
Type
journal article
Language
en
Open access
Licence
cc-by-nc-nd
Locations
  • Medicine (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
  • Natural Science Foundation of Shanghai
  • National Natural Science Foundation of China (2014QN09, 81373105)
  • Second Military Medical University
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
  • Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
  • Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
Keywords
recurrent pregnancy loss, antithrombotic therapy, low molecular weight heparin, aspirin, unfractionated heparin, antiphospholipid syndrome, thrombophilia, live birth, pregnancy loss prevention, combination therapy
MeSH terms
Abortion, Habitual, Female, Fibrinolytic Agents, Humans, Pregnancy, Antiphospholipid Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Antithrombotic Treatment for Recurrent Miscarriage: Bayesian Network Meta-Analysis and Systematic Review. https://app.cochat.ai/papers/10.1097/md.0000000000001732
The paper
Zhang, T., Ye, X., Zhu, T., XIAO, X., Liu, Y., Wei, X., Liu, Y., Wu, C., Guan, R., Li, X., Guo, X., Hu, H., & He, J. (2015). Antithrombotic Treatment for Recurrent Miscarriage: Bayesian Network Meta-Analysis and Systematic Review. Medicine. https://doi.org/10.1097/md.0000000000001732

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.